Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review by Jacob Itkin, Sudheer Dhoop, Thomas Sodeman

Subjects: “…GLP-1RAs…”
Get full text

Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment by Renjiao Liu, Dangmin Hou, Mingxin Leng, Zhouhuiling Li, Yifang Zhang, Lingling Liu, Xincheng Wang, Chunjun Li

Subjects: Get full text

Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review by Janelle Duah, David B. Seifer

Subjects: Get full text

Research progress of GLP-1RAs in the treatment of type 2 diabetes mellitus by Xu He, Xu He, Xu He, Wei Zhao, Wei Zhao, PeiHang Li, PeiHang Li, YinJiang Zhang, YinJiang Zhang, GuoHua Li, HongYu Su, BiNan Lu, BiNan Lu, ZongRan Pang, ZongRan Pang

Subjects: Get full text

MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women by Ilaria Milani, Marianna Chinucci, Frida Leonetti, Danila Capoccia

Subjects: Get full text

Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity by Andrew Overholser, Eric Czech, Linda Speer, Joel Wilson, Alex Overholser

Subjects: “…GLP-1RAs…”
Get full text

Association of GLP1RAs with risk of chronic obstructive pulmonary disease: evidence from drug target Mendelian randomization by Sijia Lai, Yaohui Feng, Lu Li, Jiayu Zhao, Zhenyu Wang, Yanli Wang

Subjects: “…GLP1RAs…”
Get full text

Advances in GLP-1 receptor agonists for pain treatment and their future potential by Yongtao He, Biao Xu, Mengna Zhang, Dan Chen, Shuyuan Wu, Jie Gao, Yongpeng Liu, Zixin Zhang, Junzhe Kuang, Quan Fang

Subjects: “…GLP-1RAs…”
Get full text

The potential biomarker value of soluble CD36 in the treatment of diabetic kidney disease: evidence from GLP-1 and insulin interventions by Wenxuan Li, Yangang Wang

Subjects: Get full text

Therapeutic potential of GLP-1RAs in sleep apnea with genetic associations to type 2 diabetes by Fang Cheng, Kang Yang, Yaoling Wang, Fan Yang, Xinyu Niu, Wei Li

Subjects: Get full text

Prescribing Antidiabetic Medications Among GPs in Croatia—A Real-Life Cross-Sectional Study by Tomislav Kurevija, Ema Schönberger, Matea Matić Ličanin, Ines Bilić-Ćurčić, Ljiljana Trtica-Majnarić, Silvija Canecki-Varžić

Subjects: Get full text

Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence by Anqi Lin, Yanxi Ding, Zhengrui Li, Aimin Jiang, Zaoqu Liu, Hank Z. H. Wong, Quan Cheng, Jian Zhang, Peng Luo

Subjects: Get full text

Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia by Tomislav Kurevija, Dunja Šojat, Ines Bilić-Ćurčić, Silvija Canecki-Varžić, Ljiljana Trtica-Majnarić

Subjects: Get full text

Efficacy and safety of glucagon-like peptide-1 receptor agonists in the elderly versus non-elderly patients with type 2 diabetes mellitus: insights from a systematic review by Yao Wang, Jiangling Wang, Qian Gong, Haoming Wu, Shuhao Yang, Jufeng He, Xulin Hu, Tianfang Huang

Subjects: “…glucagon-like peptide-1 receptor agonists (glp-1ras)…”
Get full text

Clarifying methodological approaches in the assessment of GLP-1 RAs and gastrointestinal cancer risk by Gisella Figlioli, Daniele Piovani, Spyros Peppas, Nicola Pugliese, Cesare Hassan, Alessandro Repici, Ana Lleo, Alessio Aghemo, Stefanos Bonovas

Subjects: Get full text

What Are the Experiences, Views and Perceptions of Patients, Carers and Clinicians of Glucagon‐like Peptide‐1 Receptor Agonists (GLP‐1 RAs)? A Scoping Review by Sam Febrey, Michael Nunns, Jill Buckland, Rebecca Abbott, Alison Bethel, Rebecca Whear, Kate Boddy, G. J. Melendez‐Torres, Jo Thompson Coon, Liz Shaw

Subjects: “…glucagon‐Like peptide 1 receptor agonists (GLP‐1 RAs)…”
Get full text

Efficacy of GLP‐1 Receptor Agonist‐Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta‐Analysis of Randomized Cont... by Yue Yin, Minghan Zhang, Qiuyu Cao, Lin Lin, Jieli Lu, Yufang Bi, Yuhong Chen

Subjects: Get full text

Glucagon-like peptide-1 receptor agonists in liver transplant recipients with diabetes: changes in glucose control and cardiometabolic risk factors by Valeria Grancini, Irene Cogliati, Gianfranco Alicandro, Gianfranco Alicandro, Andreina Oliverio, Clara Di Benedetto, Alessia Gaglio, Pietro Lampertico, Pietro Lampertico, Veronica Resi, Emanuela Orsi

Subjects: Get full text

The role of glucagon-like peptide-1 receptor agonists in the correction of immune and metabolic disorders in women with reproductive dysfunction by N. D. Kozhukhov, A. R. Karpova, A. A. Sadretdinova, D. G. Kodoeva, A. S. Kardanova, A. S. Proshina, A. S. Avbakirova, D. R. Kilichev, I. Sh. Metov, L. M. Magomedov, D. K. Gatsaev, M. E. Balabanova, Kh. B. Mutalieva, Z. M. Alibekova

Subjects: Get full text

Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federati... by O. K. Vikulova, G. R. Galstyan, M. V. Shestakova

Subjects: Get full text